StockWatch
·

Aspira Pathlab & Diagnostics Ltd Q2 FY26 Results

ASPIRAQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue8.0954.2%31.0%
Total Income8.2353.7%31.6%
Expenditure6.4030.9%21.5%
PBT1.84291.0%85.4%
Net Profit1.84291.0%85.4%
OPM27.05%11.41pp19.43pp
NPM22.30%13.54pp6.47pp
EPS1.78287.0%85.4%
View full financials

Informational and educational content only. Not investment advice.